To determine if platelet dysfunction and/or pharmacologic drug interaction occurs in
patients taking both AZT and ibuprofen, which might account for enhanced bleeding tendency.
Patients must have:
- HIV-seropositivity confirmed by Western Blot.
- AZT for study patients.
Patients with the following symptoms and conditions are excluded:
Hospitalization for opportunistic infection, bacterial infection or malignancy.
- AZT (for control group).
- Antibiotics or other medication for opportunistic infection, bacterial infection, or
Patients with the following prior conditions are excluded:
Hospitalization for opportunistic infection, bacterial infection, or malignancy.
- AZT 1-2 gm daily (for study patient) or not taking AZT (for control).